We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Apheresis Column Treats Dialysis-Related Amyloidosis

By HospiMedica International staff writers
Posted on 18 Mar 2015
Print article
Image: The Lixelle apheresis columns are available in three sizes (Photo courtesy of Kaneka).
Image: The Lixelle apheresis columns are available in three sizes (Photo courtesy of Kaneka).
A new device treats dialysis-related amyloidosis (DRA), a chronic, progressive condition caused by the buildup in the body of a protein called beta 2-microglobulin (B2M).

The Lixelle Beta 2-microglobulin Apheresis Column removes B2M molecules with the aid of porous cellulose beads specifically designed to bind to B2M as the patient’s blood passes over them. The filtration device is used prior to and in conjunction with hemodialysis. The device can help patients who have developed symptoms related to DRA, and may be especially useful for those patients who may not have access to extended dialysis therapies or who may not be eligible for kidney transplant.

The most common adverse events associated with use are temporary hypotension and a decrease in hematocrit, both of which are common adverse events for all patients undergoing dialysis or a similar extracorporeal therapy. The Lixelle Beta 2-microglobulin Apheresis Column is a product of Kaneka (Osaka, Japan), and has been approved by the US Food and Drug Administration (FDA) under the Humanitarian Device Exemption (HDE) pathway.

“While DRA affects only a small population of patients on dialysis, there are not many treatment options for these patients, and some options may not be available to patients in all areas,” said William Maisel, MD, MPH, chief scientist and acting director of the office of device evaluation in the FDA’s Center for Devices and Radiological Health (CDRH). “The Lixelle Beta 2-microglobulin Apheresis Column may provide this patient population with an option for relieving some of the debilitating symptoms of DRA.”

DRA is a complication of kidney failure, especially in people who have been on hemodialysis for more than five years. The buildup of B2M in the blood leads to deposits of the protein form in bones, joints, and tendons, resulting in painful and stiff joints, bone cysts that can lead to bone fractures, and torn tendons and ligaments. B2M deposits can also affect the digestive tract and internal organs such as the heart and lungs.

Related Links:

Kaneka


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Anesthesia Workstation
X40

Print article

Channels

Surgical Techniques

view channel
Image: NICO SPECTRA is only hand-held technology delivering blue light closer to target to enhance tissue fluorescence (Photo courtesy of NICO Corporation)

Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors

Grade III or IV gliomas are among the most common and deadly brain tumors, with around 20,000 cases annually in the U.S. and 1.2 million globally. These tumors are very aggressive and tend to infiltrate... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.